JP2022508523A5 - - Google Patents

Info

Publication number
JP2022508523A5
JP2022508523A5 JP2021542086A JP2021542086A JP2022508523A5 JP 2022508523 A5 JP2022508523 A5 JP 2022508523A5 JP 2021542086 A JP2021542086 A JP 2021542086A JP 2021542086 A JP2021542086 A JP 2021542086A JP 2022508523 A5 JP2022508523 A5 JP 2022508523A5
Authority
JP
Japan
Prior art keywords
pyridine
thieno
trifluoromethyl
methylcarbamoyl
piperidine
Prior art date
Application number
JP2021542086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022508523A (ja
JPWO2020072504A5 (https=
JP7545979B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/054085 external-priority patent/WO2020072504A1/en
Publication of JP2022508523A publication Critical patent/JP2022508523A/ja
Publication of JP2022508523A5 publication Critical patent/JP2022508523A5/ja
Publication of JPWO2020072504A5 publication Critical patent/JPWO2020072504A5/ja
Application granted granted Critical
Publication of JP7545979B2 publication Critical patent/JP7545979B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021542086A 2018-10-01 2019-10-01 UDPグリコシルトランスフェラーゼ阻害剤としてのチエノ[3,2-b]ピリジン誘導体および使用の方法 Active JP7545979B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862739405P 2018-10-01 2018-10-01
US62/739,405 2018-10-01
PCT/US2019/054085 WO2020072504A1 (en) 2018-10-01 2019-10-01 Thieno[3,2-b]pyridine derivatives as udp glycosyltransferase inhibitors and methods of use

Publications (4)

Publication Number Publication Date
JP2022508523A JP2022508523A (ja) 2022-01-19
JP2022508523A5 true JP2022508523A5 (https=) 2022-09-07
JPWO2020072504A5 JPWO2020072504A5 (https=) 2022-09-07
JP7545979B2 JP7545979B2 (ja) 2024-09-05

Family

ID=68296740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021542086A Active JP7545979B2 (ja) 2018-10-01 2019-10-01 UDPグリコシルトランスフェラーゼ阻害剤としてのチエノ[3,2-b]ピリジン誘導体および使用の方法

Country Status (15)

Country Link
US (1) US11098056B2 (https=)
EP (1) EP3861000A1 (https=)
JP (1) JP7545979B2 (https=)
KR (1) KR102903997B1 (https=)
CN (1) CN113423711B (https=)
AU (1) AU2019355870B2 (https=)
BR (1) BR112021005914A2 (https=)
CA (1) CA3114722A1 (https=)
CO (1) CO2021005738A2 (https=)
IL (1) IL281811B2 (https=)
MA (1) MA53043B2 (https=)
MX (1) MX2021003794A (https=)
SG (1) SG11202102987VA (https=)
TW (1) TWI821426B (https=)
WO (1) WO2020072504A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202302565A (zh) * 2021-02-19 2023-01-16 英商卡爾維斯塔製藥有限公司 酶抑制劑
EP4483954A1 (en) * 2023-06-29 2025-01-01 Masarykova Univerzita Substituted thieno [3,2-b]pyridines as inhibitors of protein kinases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3763156A (en) * 1970-01-28 1973-10-02 Boehringer Sohn Ingelheim 2-heterocyclic amino-4-morpholinothieno(3,2-d)pyrimidines
US7375125B2 (en) * 1999-08-04 2008-05-20 Ore Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
MXPA02001160A (es) 1999-08-04 2002-07-02 Millennium Pharm Inc Compuestos que se unen a los receptores para melanocortina-4, y metodo de uso de estos.
FR2821356A1 (fr) * 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
EP3109249A1 (en) * 2007-11-15 2016-12-28 YM BioSciences Australia Pty Ltd N-containing heterocyclic compounds
MX2011008276A (es) * 2009-02-06 2011-12-14 Elan Pharm Inc Inhibidores de quinasa jun n-terminal.
JP2014511391A (ja) * 2011-03-07 2014-05-15 フォンダッツィオーネ・テレソン Tfebリン酸化阻害剤およびその使用
ES2928714T3 (es) * 2015-01-16 2022-11-22 Massachusetts Gen Hospital Compuestos para mejorar el empalme del ARNm
JP7114076B2 (ja) 2015-12-22 2022-08-08 シャイ・セラピューティクス・エルエルシー がん及び炎症性疾患の処置のための化合物
SG11201809693SA (en) * 2016-05-05 2018-11-29 Lysosomal Therapeutics Inc SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
WO2017214505A1 (en) * 2016-06-10 2017-12-14 Biomarin Pharmaceutical Inc. Ceramide galactosyltransferase inhibitors for the treatment of disease
MY193511A (en) * 2016-11-02 2022-10-17 Janssen Pharmaceutica Nv [1,2,4]triazolo[1,5-a]pyrimidine derivatives as pde2 inhibitors
WO2018118838A1 (en) * 2016-12-20 2018-06-28 Biomarin Pharmaceutical Inc. Ceramide galactosyltransferase inhibitors for the treatment of disease
EP3619209A1 (en) * 2017-05-04 2020-03-11 Glenmark Pharmaceuticals S.A. Substituted bicyclic heterocyclic compounds as nadph oxidase inhibitors
JP7514005B2 (ja) 2017-06-21 2024-07-10 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ラソパシー、及び線維性疾患の治療のためのrasスーパーファミリーと相互作用する化合物

Similar Documents

Publication Publication Date Title
US11739098B2 (en) Substituted indole compounds
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
JPWO2020005877A5 (https=)
HRP20210935T1 (hr) Spojevi 5-kloro-2-difluorometoksifenil pirazolopirimidina koji predstavljaju inhibitore jak
JP2014506929A5 (https=)
JP2021519291A5 (https=)
JP2018530557A5 (https=)
JP2018530557A (ja) 置換ピラゾロ[3,4−b]ピリジン−6−カルボン酸およびこの使用
JPWO2019191229A5 (https=)
RU2016135637A (ru) 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение
JP2015522002A5 (https=)
JP2015523387A5 (https=)
HRP20250272T1 (hr) Derivati benzimidazola i njihova uporaba
JP2017505327A5 (https=)
JP2015537010A5 (https=)
JP2018529743A (ja) N−スルホニル化ピラゾロ[3,4−b]ピリジン−6−カルボキサミドおよび使用法
JPWO2020005873A5 (https=)
JP2015504057A5 (https=)
RU2020129785A (ru) Фармацевтические производные 6,5-гетеробициклического кольца
US11840528B2 (en) Isoxazolyl ether derivatives as GABAA α5 PAM
JPWO2022147246A5 (https=)
JPWO2020231977A5 (https=)
JP2022508523A5 (https=)
RU2020127848A (ru) Производные 4-гидроксипиперидина и их применение в качестве ингибиторов убиквитин-специфической протеазы 19 (usp19)